Dectrekumab Biosimilar – Anti-IL13 mAb – Research Grade

Reference:
Product nameDectrekumab Biosimilar - Anti-IL13 mAb - Research Grade
SourceCAS 1528523-94-5
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsDectrekumab,QAX-576,IL13,anti-IL13
ReferencePX-TA1375
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Dectrekumab Biosimilar - Anti-IL13 mAb - Research Grade

General information on Anti-IL13[Homo sapiens] (Dectrekumab) Monoclonal Antibody

Dectrekumab is investigated for the prevention of Keloid Recurrence.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Dectrekumab Biosimilar – Anti-IL13 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

IL13 recombinant protein
Antigen

IL13 recombinant protein

PX-P5175 385€
IL13, N-His, recombinant protein
Antigen

IL13, N-His, recombinant protein

PX-P5778 385€
Human CD213a2 / IL13RA2 recombinant protein
Antigen

Human CD213a2 / IL13RA2 recombinant protein

PX-P6041 385€
Stable Isotope Labelled Dectrekumab Biosimilar – Anti-IL13 mAb – Research Grade
SIL

Stable Isotope Labelled Dectrekumab Biosimilar – Anti-IL13 mAb – Research Grade

PX-TA1375-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products